share_log

Vericel Says US FDA Approves SBLA for Tissue Restoring Knee Repair Treatment - Shares Up Pre-Bell

Vericel Says US FDA Approves SBLA for Tissue Restoring Knee Repair Treatment - Shares Up Pre-Bell

Vericel表示美國FDA批准了SBLA用於組織修復膝部治療的治療-股價大漲前貝爾
MT Newswires ·  08/26 08:51

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論